Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections
- 20 September 2022
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (9) , e0231821
Abstract
Multidrug-resistant (MDR) N. gonorrhoeae is a current public health threat. New therapies are urgently needed. PBT2 is an ionophore that disrupts metal homeostasis. PBT2 administered with zinc is shown to reverse resistance to antibiotics in several bacterial pathogens. Here we show that both N. meningitidis and MDR N. gonorrhoeae are sensitive to killing by PBT2 alone. PBT2 is, thus, a candidate therapeutic for MDR N. gonorrhoeae infections.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (1071659)
- Department of Health | National Health and Medical Research Council (1138466)
- Department of Health | National Health and Medical Research Council (1176180)
- Department of Health | National Health and Medical Research Council (1196520)
- Department of Health | National Health and Medical Research Council (1194130)
- Department of Health | National Health and Medical Research Council (2001210)
This publication has 22 references indexed in Scilit:
- Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodiesBiochemical and Biophysical Research Communications, 2013
- Tackling antibiotic resistanceNature Reviews Microbiology, 2011
- Multiresistant Gram-negative infections: a global perspectiveCurrent Opinion in Infectious Diseases, 2010
- Manganese regulation of virulence factors and oxidative stress resistance in Neisseria gonorrhoeaeJournal of Proteomics, 2010
- Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposesJournal of Antimicrobial Chemotherapy, 2009
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trialThe Lancet Neurology, 2008
- Characterization of the OxyR regulon of Neisseria gonorrhoeaeMolecular Microbiology, 2006
- PerR controls Mn‐dependent resistance to oxidative stress inNeisseria gonorrhoeaeMolecular Microbiology, 2006
- Regulation of mtrF Expression in Neisseria gonorrhoeae and Its Role in High-Level Antimicrobial ResistanceJournal of Bacteriology, 2005
- Antibacterial resistance worldwide: causes, challenges and responsesNature Medicine, 2004